Document:

Comprehensive Associates LLC Consulting agreement

    COMPREHENSIVE
      HEALTHCARE SOLUTIONS, INC.

     

    REGISTRATION
      RIGHTS AGREEMENT

     

    THIS
      REGISTRATION RIGHTS AGREEMENT
      (the
“Agreement”)
      is
      made as of August 3, 2005 by and between COMPREHENSIVE
      HEALTHCARE SOLUTIONS, INC.,
      a
      Delaware corporation (the “Company”),
      and
COMPREHENSIVE
      ASSOCIATES LLC,
      a New
      York limited liability company (together with its successors and assigns, the
      “Holder”).

     

    R
      E C I T A L S:

     

    Pursuant
      to the terms of Convertible Debentures, dated as of the date hereof, in the
      aggregate principal amount of $235,000 (the “Aggregate
      Principal Amount”)
      executed by the Company in favor of the Holder (the “Debentures”),
      and
      pursuant to the terms of Warrants, dated as of the date hereof, for the purchase
      of an aggregate of 5,000,000 shares of Common Stock, par value $.10 per share,
      of the Company (“Common
      Stock”)
      executed by the Company in favor of the Holder (the “Warrants”),
      the
      Holder will have the right to acquire in the future certain shares of Common
      Stock. The Debentures and Warrants are collectively are referred to herein
      as
      the “Securities.”

     

    The
      parties desire to set forth herein their agreement as to the terms and
      conditions of certain registration rights relating to the Common Stock issuable
      upon conversion or exercise of the Securities, as applicable, by the
      Holder.

     

    A
      G R E E M E N T:

     

    The
      parties hereto agree as follows:

     

    1.    Certain
      Definitions.
      As used
      in this Agreement, the following terms shall have the following respective
      meanings:

     

    “Commission”
shall
      mean the Securities and Exchange Commission.

     

    “Exchange
      Act”
shall
      mean the Securities Exchange Act of 1934, as amended, and the rules and
      regulations of the Commission promulgated thereunder, all as the same shall
      be
      in effect from time to time.

     

    “Holder”
shall
      mean the Holder (as hereinabove defined) and any Person who shall have acquired
      Registrable Securities from the Holder, either individually or jointly, as
      the
      case may be, in a transaction pursuant to which registration rights are
      transferred pursuant to Section 7 hereof.

     

    “Person”
shall
      mean an individual, a partnership, a corporation, a limited liability company,
      an association, a joint stock company, a trust, a joint venture, an
      unincorporated organization or a governmental or quasi-governmental entity,
      or
      any department, agency or political subdivision thereof or any other entity
      of
      any kind.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    “Prospectus”
shall
      mean the prospectus included in the Registration Statement (including, without
      limitation, a prospectus that includes any information previously omitted from
      a
      prospectus filed as part of an effective Registration Statement in reliance
      upon
      Rule 430A promulgated under the Securities Act), as amended or supplemented
      by
      any prospectus supplement, with respect to the terms of the offering of any
      portion of the Registrable Securities covered by the Registration Statement,
      and
      all other amendments and supplements to the Prospectus, including post-effective
      amendments, and all material incorporated by reference or deemed to be
      incorporated by reference in such Prospectus.

     

    “Registrable
      Securities”
shall
      mean (i) any and all shares of Common Stock issuable upon conversion of the
      Debentures, and (ii) any and all shares of Common Stock issuable upon exercise
      of the Warrants. 

     

    The
      terms
“register,”
      “registered”
and
      “registration”
refer
      to a registration effected by preparing, filing and having declared effective
      a
      registration statement in compliance with the Securities Act.

     

    “Registration
      Expenses”
shall
      mean (i) all expenses, other than Selling Expenses (defined below), incurred
      by
      the Company in complying with Section 2 hereof, including without limitation,
      all registration, qualification and filing fees, exchange or quotation medium
      listing fees, printing and delivery expenses, escrow and custodian fees, fees
      and disbursements of counsel for the Company, blue sky fees and expenses and
      the
      expenses of accountants for the Company including the expenses of any special
      audits incident to or required by any such registration and (ii) the reasonable
      fees and disbursements of one counsel chosen by the Holder in connection with
      the Registration Statement.

     

    “Registration
      Statement”
shall
      mean an initial registration statement which is required to register the resale
      of all Registrable Securities and, in each case, the Prospectus, amendments
      and
      supplements to such registration statement or Prospectus, including pre- and
      post-effective amendments, all exhibits thereto, and all material incorporated
      by reference or deemed to be incorporated by reference in such registration
      statement.

     

    “Securities
      Act”
shall
      mean the Securities Act of 1933, as amended, and the rules and regulations
      of
      the Commission promulgated thereunder, all as the same shall be in effect from
      time to time.

     

    “Selling
      Expenses”
shall
      mean all underwriting discounts, selling commissions and stock transfer taxes
      and the costs, fees and expenses of any accountants, attorneys (other than
      the
      cost, fees and expenses of attorneys which are Registration Expenses) or other
      experts retained by the Holder.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    2.  Required
      Registration.

     

    (a)  The
      Company shall prepare and file, as soon as is reasonably practicable, but in
      no
      event later than the thirtieth (30th)
      day
      following the date hereof (the “Filing
      Date”),
      a
      Registration Statement under the Securities Act covering the resale of the
      Registrable Securities and shall use its best efforts to cause the Registration
      Statement to become effective as expeditiously as possible, but in no event
      later than the earlier of (i) the one hundred twentieth (120th)
      day
      following the date hereof or (ii) the third day following the date on which
      the
      Company is notified by the Commission that the Registration Statement will
      not
      be reviewed or is no longer subject to further review and comments (the
“Effectiveness
      Date”),
      and
      shall use its best efforts to keep the Registration Statement continuously
      effective under the Securities Act until the date which is six (6) years
      following the date hereof (the “Effectiveness
      Period”).

     

    (b)  If:
      

     

    (i) the
      Registration Statement is not filed with the Commission on or prior to the
      Filing Date (if the Company files the Registration Statement with the Commission
      without affording the Holder the opportunity to review and comment on the same
      as required by Section 5(a), the Company shall be deemed not to have filed
      the
      Registration Statement with the Commission on or prior to the Filing Date),
      or

     

    (ii) the
      Company fails to file with the Commission a request for acceleration in
      accordance with Rule 461 promulgated under the Securities Act, within two (2)
      days of the date that the Company is notified (orally or in writing, whichever
      is earlier) by the Commission that the Registration Statement will not be
“reviewed,” or not subject to further review, or 

     

    (iii) the
      Registration Statement filed or required to be filed hereunder is not declared
      effective by the Commission by the Effectiveness Date, or 

     

    (iv) after
      the
      date that the Registration Statement is initially declared effective by the
      Commission (the “Effective
      Date”),
      the
      Registration Statement ceases for any reason to remain continuously effective
      as
      to all Registrable Securities, or the Holder is not permitted to utilize the
      Prospectus therein to resell such Registrable Securities,  (any
      such
      failure or breach being referred to as an “Event,”
and
      for purposes of clause (i), (iii) or (iv), the date on which such Event occurs,
      or for purposes of clause (ii) the date on which such two (2) day period is
      exceeded, being referred to as “Event
      Date”),
      then
      for an Event: (x) on each such Event Date, the Company shall pay to the Holder
      an amount in cash, as liquidated damages and not as a penalty, equal to one
      and
      one-half percent (1.5%) of the initial Aggregate Principal Amount; and (y)
      on
      each monthly anniversary of each such Event Date (if the applicable Event shall
      not have been cured by such date) until the applicable Event is cured, the
      Company shall pay to the Holder an amount in cash, as liquidated damages and
      not
      as a penalty, equal to one and one-half percent (1.5%) of the initial Aggregate
      Principal Amount. Notwithstanding the foregoing, no damages shall be payable
      with respect to an Event if liquidated damages are payable hereunder with
      respect to another Event at such time. 

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

       

       

      If
        the
        Company fails to pay any liquidated damages pursuant to this Section in full
        within fifteen (15) days after the date payable, the Company will pay interest
        thereon at a rate of sixteen percent (16%) per annum (or such lesser maximum
        amount that is permitted to be paid by applicable law) to the Holder, accruing
        daily from the date such liquidated damages are due until such amounts, plus
        all
        such interest thereon, are paid in full. 

    

     

    (c)  [intentionally
      omitted]

     

    (d)  The
      Company represents and warrants that it is not a party to, or otherwise subject
      to, any agreement, other than this Agreement, granting registration rights
      to
      any other Person with respect to any securities of the Company and agrees that
      it will not include any securities of the Company, other than the Registrable
      Securities, in the Registration Statement. Notwithstanding the foregoing, the
      Company may include in the Registration Statement up to 50,000 shares of Common
      Stock on behalf of Anslow & Jaclin, LLP.

     

    3.  Expenses
      of Registration.

     

    All
      Registration Expenses incurred in connection with the Registration Statement
      pursuant to Section 2 hereof shall be borne by the Company. All Selling Expenses
      relating to securities registered on behalf of the Holder shall be borne by
      the
      Holder.

     

    4.  Holdback
      Agreements.

     

    The
      Company agrees not to effect any public sale or distribution of its equity
      securities, or any securities convertible into or exchangeable or exercisable
      for such securities, during the ten (10) day period prior to, and during the
      ninety (90) day period following, the Effective Date. None of the Company’s
      executive officers, directors, or holders of at least 5% of the outstanding
      Common Stock will effect any public sale or distribution (including sales
      pursuant to Rule 144) of any such securities during such periods. 

     

    5.  Registration
      Procedures.

     

    The
      Company will use its best efforts to effect the registration of the Registrable
      Securities in accordance with the intended method or methods of distribution
      thereof, and pursuant thereto the Company will under the time frames provided
      herein, or if not so provided, as expeditiously as possible:

     

    (a)  prepare
      and file with the Commission the Registration Statement on any appropriate
      form
      for which the Company qualifies with respect to such Registrable Securities
      and
      use its best efforts to cause the Registration Statement to become effective
      (provided
      that
      before filing the Registration Statement or Prospectus or any amendments or
      supplements thereto, the Company will (i) furnish to the counsel selected by
      the
      Holder copies of all such documents proposed to be filed, which documents will
      be subject to the review of such counsel for a period of seven (7) days
      following the receipt thereof, and (ii) notify the Holder covered by such
      registration of any stop order issued or threatened by the
      Commission);

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    (b)  prepare
      and file with the Commission such amendments and supplements to the Registration
      Statement and the Prospectus used in connection therewith as may be reasonably
      necessary to keep the Registration Statement effective for the Effectiveness
      Period or until the time by which all of the Registrable Securities have been
      sold, and comply with the provisions of the Securities Act with respect to
      the
      disposition of the Registrable Securities during such period in accordance
      with
      the intended methods of disposition by the Holder set forth in the Registration
      Statement;

     

    (c)  furnish
      to the Holder such number of copies of the Registration Statement, each
      amendment and supplement thereto, the Prospectus included in the Registration
      Statement (including each preliminary Prospectus) and such other documents
      as
      the Holder may reasonably request in order to facilitate the disposition of
      the
      Registrable Securities owned by the Holder;

     

    (d)  use
      its
      best efforts to register or qualify the Registrable Securities under the
      securities or blue sky laws of such jurisdictions as the Holder reasonably
      requests and do any and all other acts and things which may be reasonably
      necessary or advisable to enable the Holder to consummate the disposition in
      such jurisdictions of the Registrable Securities owned by the Holder
      (provided
      that the
      Company will not be required to (i) qualify generally to do business in any
      jurisdiction where it would not otherwise be required to qualify but for this
      Section 5(d), (ii) subject itself to taxation in any jurisdiction or (iii)
      take
      any action that would subject it to general service of process in any such
      jurisdiction);

     

    (e)  promptly
      notify the Holder, at any time when the Prospectus relating thereto is required
      to be delivered under the Securities Act, of the happening of any event as
      a
      result of which the Prospectus included in the Registration Statement contains
      an untrue statement of a material fact or omits any material fact necessary
      to
      make the statements therein not misleading, and the Company will prepare and
      deliver to the Holder a supplement or amendment to such Prospectus so that,
      as
      thereafter delivered to the purchasers of such Registrable Securities, such
      Prospectus will not contain an untrue statement of a material fact or omit
      to
      state any material fact necessary to make the statements therein not misleading;
      

     

    (f)  cause
      all
      Registrable Securities to be listed on each securities exchange or quoted on
      Nasdaq or other quotation medium, if any, on which similar securities issued
      by
      the Company are then listed or quoted;

     

    (g)  provide
      a
      transfer agent for all Registrable Securities not later than the Effective
      Date;

     

    (h)  enter
      into such customary agreements (including underwriting agreements in customary
      form) and take all such other actions as the Holder or the underwriters, if
      any,
      reasonably request in order to expedite or facilitate the disposition of the
      Registrable Securities;

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    (i)  make
      available for inspection by the Holder, any underwriter participating in any
      disposition pursuant to the Registration Statement and any attorney, accountant
      or other agent retained by the Holder or underwriter, all pertinent financial
      and other records, pertinent corporate documents and properties of the Company,
      and cause the Company’s officers, directors, employees and independent
      accountants to supply all information reasonably requested by the Holder,
      underwriter, attorney, accountant or agent in connection with the Registration
      Statement and (ii) to participate in presentations to prospective purchasers
      as
      reasonably requested by any underwriter;

     

    (j)  otherwise
      use its best efforts to comply with all applicable rules and regulations of
      the
      Commission, and make available to its security holders, as soon as reasonably
      practicable, an earnings statement covering the period of at least twelve (12)
      months beginning with the first day of the Company’s first full calendar quarter
      after the Effective Date, which earnings statement shall satisfy the provisions
      of Section 11(a) of the Securities Act and Rule 158 thereunder;

     

    (k)  in
      the
      event of the issuance of any stop order suspending the effectiveness of the
      Registration Statement, or of any order suspending or preventing the use of
      any
      related Prospectus or suspending the qualification of any shares of Common
      Stock
      included in the Registration Statement for sale in any jurisdiction, use its
      best efforts promptly to obtain the withdrawal of such order;

     

    (l)  if
      requested by the Holder, obtain a so-called “cold comfort” letter from the
      Company’s independent public accountants in customary form and covering such
      matters of the type customarily covered by cold comfort letters;

     

    (m)  use
      its
      best efforts to cause the Registrable Securities to be registered with or
      approved by such other governmental agencies or authorities as may be necessary
      to enable the Holder to consummate the disposition of such Registrable
      Securities. 

     

    6.  Indemnification.

     

    (a)  The
      Company agrees to indemnify, to the fullest extent permitted by applicable
      law,
      the Holder, its officers, directors, members and managers, and each Person
      who
      controls the Holder (within the meaning of the Securities Act) against all
      losses, claims, damages, liabilities, expenses or any amounts paid in settlement
      of any litigation, investigation or proceeding commenced or threatened
      (collectively, “Claims”)
      to
      which each such indemnified party may become subject under the Securities Act
      insofar as such Claim arose out of (i) any untrue or alleged untrue statement
      of
      material fact contained in the Registration Statement, Prospectus or preliminary
      Prospectus or any amendment thereof or supplement thereto or (ii) any omission
      or alleged omission to state therein a material fact required to be stated
      therein or necessary to make the statements therein not misleading, except
      insofar as the same are caused by or contained in any information furnished
      in
      writing to the Company by the Holder expressly for use therein. In connection
      with an underwritten offering, the Company will indemnify the underwriters,
      their officers and directors and each Person who controls the underwriters
      (within the meaning of the Securities Act) to the same extent as provided above
      with respect to the indemnification of the Holder.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    (b)  The
      Holder will, to the fullest extent permitted by applicable law, indemnify the
      Company, its directors and officers and each Person who controls the Company
      (within the meaning of the Securities Act) against any and all Claims to which
      each such indemnified party may become subject under the Securities Act insofar
      as such Claim arose out of (i) any untrue or alleged untrue statement of
      material fact contained in the Registration Statement, Prospectus or preliminary
      Prospectus or any amendment thereof or supplement thereto, or (ii) any omission
      or alleged omission to state therein a material fact required to be stated
      therein or necessary to make the statements therein not misleading; provided
      that
      with respect to a Claim arising pursuant to clause (i) or (ii) above, the
      material misstatement or omission is contained in information the Holder
      provided to the Company expressly for use therein; provided,
      further,
      that
      the obligation to indemnify will be limited to the amount of proceeds received
      by the Holder from the sale of Registrable Securities pursuant to the
      Registration Statement.

     

    (c)  Any
      Person entitled to indemnification hereunder will give written notice to the
      indemnifying party of any claim with respect to which it seeks indemnification
      (but the failure to provide such notice shall not release the indemnifying
      party
      of its obligation under paragraphs (a) and (b) unless, and then only to the
      extent that, the indemnifying party has been prejudiced by such failure to
      provide such notice). At the request of the indemnified party, the indemnifying
      party shall assume the defense of such claim with counsel reasonably
      satisfactory to the indemnified party. 

     

    (d)  The
      indemnifying party shall not be liable to indemnify an indemnified party for
      any
      settlement, or consent to judgment of any such action effected without the
      indemnifying party’s written consent (but such consent will not be unreasonably
      withheld, delayed or conditioned). Furthermore, if the indemnifying party
      assumes the defense of a claim, the indemnifying party shall not, except with
      the prior written approval of each indemnified party, consent to entry of any
      judgment or enter into any settlement which does not include as an unconditional
      term thereof the giving by the claimant or plaintiff to each indemnified party
      of a release (in form and substance satisfactory to each indemnified party)
      from
      all liability in respect of such claim or litigation without any payment or
      consideration provided by each such indemnified party.

     

    (e)  If
      the
      indemnification provided for in this Section 6 is unavailable to an indemnified
      party under clauses (a) and (b) above in respect of any losses, claims, damages
      or liabilities referred to therein, then each indemnifying party, in lieu of
      indemnifying such indemnified party, shall contribute to the amount paid or
      payable by such indemnified party as a result of such losses, claims, damages
      or
      liabilities in such proportion as is appropriate to reflect not only the
      relative benefits received by the Company, the underwriters, and the Holder
      from
      the sale of the Registrable Securities pursuant to the registered offering
      of
      securities for which indemnity is sought but also the 

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

       

       

      relative
        fault of the Company, the underwriters and the Holder in connection with
        the
        misstatement or omission which resulted in such losses, claims, damages or
        liabilities, as well as any other relevant equitable considerations. The
        relative benefits received by the Company, the underwriters and the Holder
        shall
        be deemed to be based on the relative relationship of the total net proceeds
        from the offering (before deducting expenses) to the Company, the total
        underwriting commissions and fees from the offering (before deducting expenses)
        to the underwriters and the total net proceeds from the offering (before
        deducting expenses) to the Holder. The relative fault of the Company, the
        underwriters and the Holder shall be determined by reference to, among other
        things, whether the untrue or alleged untrue statement of a material fact
        or the
        omission or alleged omission to state a material fact relates to information
        supplied by the Company or by the Holder and the parties’ relative intent,
        knowledge, access to information and opportunity to correct or prevent such
        statement or omission; provided
        that in
        no event shall the liability of the Holder hereunder be greater in amount
        than
        the dollar amount of the proceeds received by the Holder upon the sale of
        the
        Registrable Securities giving rise to such indemnification
        obligation.

    

     

    (f)  The
      indemnification provided for under this Agreement will remain in full force
      and
      effect regardless of any investigation made by or on behalf of the indemnified
      party or any officer, director or controlling person of such indemnified party
      and will survive the transfer of the Registrable Securities.

     

    7.  Transfer
      of Registration Rights.

     

    The
      rights granted to the Holder under this Agreement may be assigned to any Person
      in connection with any transfer or assignment of Registrable Securities by
      the
      Holder. 

     

    8.  Exchange
      Act Compliance.

     

    The
      Company shall comply with all of the reporting requirements of the Exchange
      Act
      then applicable to it, if any, and shall comply with all other public
      information reporting requirements of the Commission which are conditions to
      the
      availability of Rule 144 for the sale of the Registrable Securities. The Company
      shall cooperate with the Holder in supplying such information as may be
      necessary for such Holder to complete and file any information reporting forms
      presently or hereafter required by the Commission as a condition to the
      availability of Rule 144.

     

    9.  Miscellaneous.

     

    (a)  No
      Inconsistent Agreements.
      So long
      as the Holder owns any Registrable Securities, the Company will not enter into
      any agreement that is inconsistent with or violates the rights granted hereunder
      to the Holder, including, without limitation, any agreement that would require
      the Company to register any of its securities with priority with respect to
      registration over the rights granted to the Holder hereunder, without the prior
      written consent of the Holder. 

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    (b)  Remedies.
      The
      Holder will be entitled to enforce its rights specifically to recover damages
      caused by reason of any breach of any provision of this Agreement and to
      exercise all other rights granted by law. The parties hereto agree and
      acknowledge that money damages may not be an adequate remedy for any breach
      of
      the provisions of this Agreement and that the Holder may in its sole discretion
      apply to any court of law or equity of competent jurisdiction (without posting
      any bond or other security) for specific performance and for other injunctive
      relief in order to enforce or prevent violation of the provisions of this
      Agreement.

     

    (c)  Amendments
      and Waivers.
      The
      provisions of this Agreement may be amended or waived only with the prior
      written consent of the Company and the Holder. 

     

    (d)  Successors
      and Assigns.
      This
      Agreement and all of the provisions hereof shall be binding upon and inure
      to
      the benefit of the parties and their respective successors and assigns. In
      addition, whether or not any express assignment has been made, the provisions
      of
      this Agreement which are for the benefit of Holder are also for the benefit
      of,
      and enforceable by, any transferee of Registrable Securities, in accordance
      with
      Section 7 hereof.

     

    (e)  Severability.
      In case
      any provision of this Agreement shall be invalid, illegal or unenforceable,
      the
      validity, legality and enforceability of the remaining provisions shall not
      be
      in any way affected or impaired thereby.

     

    (f)  Counterparts
      and Facsimile.
      This
      Agreement may be executed in any number of counterparts, and each such
      counterpart hereof shall be deemed to be an original instrument, but all such
      counterparts together shall constitute one agreement. This Agreement may be
      signed and delivered to the other party by facsimile transmission; such
      transmission shall be deemed a valid signature.

     

    (g)  Descriptive
      Headings.
      The
      section and paragraph headings contained in this Agreement are for reference
      purposes only and shall not affect in any way the meaning or interpretation
      of
      this Agreement.

     

    (h)  Governing
      Law.
      This
      Agreement shall be governed by and construed in accordance with the internal
      laws of the State of New York, without giving effect to conflicts of laws rules
      or principles. 

     

    (i)  Notices.
      All
      notices, demands and requests of any kind to be delivered to any party in
      connection with this Agreement shall be in writing and shall be deemed to have
      been duly given if personally or hand delivered or if sent by a recognized
      overnight courier or by registered or certified mail, return receipt requested
      and postage prepaid, or by facsimile transmission, addressed as
      follows:

     

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

                          

     

                          (i)  if
      to the
      Company, to:

     

    Comprehensive
      Healthcare Solutions, Inc.

    45
      Ludlow
      Street, Suite 602

    Yonkers,
      New York 10705

    Attention:
      John H. Treglia, Chairman of the Board & Chief Executive
      Officer

    Facsimile:
      (914) 375-3696

    

    with
      a
      copy to:

    

    Anslow
      & Jaclin, LLP

    195
      Route
      9, Suite 204

    Manalapan,
      New Jersey 07726

    Attention:
      Gregg E. Jaclin, Esq.

    Facsimile:
      (732) 577-1188

     

    (ii)  if
      to the
      Holder, to:

    

    Comprehensive
      Associates LLC

    64
      Shelter Lane

    Roslyn,
      New York 11577

    Attention:
      Robyn Schreiber

    Facsimile:
      (516) 621-9172

    

    with
      a
      copy to:

    

    Certilman
      Balin Adler & Hyman, LLP

    90
      Merrick Avenue, 9th Floor

    East
      Meadow, New York 11554

    Attention:
      Fred Skolnik, Esq.

    Facsimile:
      (516) 296-7111

    

    or
      to
      such other address as the party to whom notice is to be given may have furnished
      to the other party hereto in writing in accordance with provisions of this
      Section 9(i). Any such notice or communication shall be deemed to have been
      effectively given (i) in the case of personal or hand delivery, on the date
      of
      such delivery, (ii) in the case of a recognized overnight delivery courier,
      on
      the business day after the date when sent or earlier upon receipt of evidence
      of
      acceptance of delivery, (iii) in the case of mailing, on the third business
      day
      following that day on which the piece of mail containing such communication
      is
      posted and (iv) in the case of facsimile transmission, on the date of
      transmission.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

     

     

    (j)  Entire
      Agreement.
      This
      Agreement constitutes the full and entire understanding and agreement of the
      parties with regard to the subject matter hereof and supersedes all prior
      agreements and understandings among the parties with respect
      thereto.

     

    {Remainder
      of page intentionally left blank. Signature page to
      follow.}

     

    

     

    
      
        
          

        

         

      

      
         

        
          

        

      

      
         

        
        

      

    

    IN
      WITNESS WHEREOF,
      the
      parties have executed this Registration Rights Agreement as of the date first
      written above.

     

    

    COMPREHENSIVE
      HEALTHCARE

    SOLUTIONS,
      INC.

    

     

    By:
            

    John
      H.
      Treglia, 

    Chairman
      of the Board & Chief Executive Officer

    

     

    COMPREHENSIVE
      ASSOCIATES LLC      

     

    By:   
      The Nybor Group, Inc., Managing Member

    

    

    By:_________________________________

    Robyn
      Schreiber, President

    

    

    

    

    Agreed
      as
      to Section 4:

    

    

     

    John
      H.
      Treglia     

    

     

    Paul
      Rothman               

    ____________________________________

    Carlyn
      A.
      Barr  

    

    ____________________________________

    Dr.
      Frank
      J. Castanaro

    

    ____________________________________

    Baruch
      MoskowitzNite Capital, LP Convertible note

    THE
      SECURITIES REPRESENTED BY THIS WARRANT CERTIFICATE AND THE SHARES OF COMMON
      STOCK ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
      OR APPLICABLE STATE SECURITIES LAWS AND NO INTEREST THEREIN MAY BE SOLD,
      TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS (1) A REGISTRATION STATEMENT WITH
      RESPECT TO SUCH SECURITIES SHALL BE EFFECTIVE UNDER THE ACT AND ANY APPLICABLE
      STATE SECURITIES LAWS OR (2) SUCH SECURITIES ARE TRANSFERRED PURSUANT TO RULE
      144 PROMULGATED UNDER THE ACT (OR ANY SUCCESSOR RULE) OR (3) COMPREHENSIVE
      HEALTHCARE SOLUTIONS, INC. SHALL HAVE RECEIVED AN OPINION OF COUNSEL REASONABLY
      SATISFACTORY TO IT THAT NO VIOLATION OF THE ACT WILL BE INVOLVED IN SUCH
      TRANSFER.

     

    COMPREHENSIVE
      HEALTHCARE SOLUTIONS, INC.

     

    EXERCISABLE
      AT OR BEFORE

     

    5:00
      P.M., EASTERN TIME, AUGUST __, 2010

     

    No.
      3                                                                                                                                                                       Warrant
      to Purchase

                                                                                                                                                                                  2,000,000
      Shares

     

    WARRANT
      TO PURCHASE SHARES

     

    OF
      COMMON STOCK

     

    THIS
      CERTIFIES THAT,
      for
      value received, COMPREHENSIVE
      ASSOCIATES LLC,
      a New
      York limited liability company (together with its successors and assigns, the
      “Holder”),
      with
      offices at 64 Shelter Lane, Roslyn, New York 11577, is entitled to subscribe
      for
      and purchase up to TWO
      MILLION (2,000,000)
      shares,
      as adjusted pursuant to Section 4 (the “Shares”),
      of
      the fully paid and nonassessable common stock, par value $.10 per share (the
      “Common
      Stock”)
      of
COMPREHENSIVE
      HEALTHCARE SOLUTIONS, INC.,
      a
      Delaware corporation (the “Company”),
      at
      the price of FIFTY
      CENTS ($0.50)
      per
      share (such price, and such other prices that shall result from time to time,
      from the adjustments specified in Section 4, the “Warrant
      Price”),
      subject to the provisions and upon the terms and conditions hereinafter set
      forth.

     

    1.  Term.
      The
      purchase right represented by this Warrant is exercisable, in whole or in part,
      at any time, and from time to time, from and after the date hereof and until
      5:00 p.m., Eastern Time, August __, 2010. 

     

    2.  Method
      of Exercise; Payment; Issuance of New Warrant.
      

     

    (a)  The
      purchase right represented by this Warrant may be exercised by the Holder,
      in
      whole or in part and from time to time, by the surrender of this Warrant (with
      the notice of exercise form attached hereto as Annex I
      duly
      executed) at the principal office of the Company and by the payment to the
      Company of the Warrant Price in cash. 

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    (b)  The
      persons or entities in whose name(s) any certificate(s) representing Shares
      shall be issuable upon exercise of this Warrant shall be deemed to have become
      the holder(s) of record of, and shall be treated for all purposes as the record
      holder(s) of, the Shares represented thereby (and such Shares shall be deemed
      to
      have been issued) immediately prior to the close of business on the date or
      dates upon which this Warrant is properly exercised and full payment for the
      Shares acquired pursuant to such exercise is made. Upon any exercise of the
      rights represented by this Warrant, certificates for the Shares purchased shall
      be delivered to the Holder hereof within one (1) day of receipt of such notice
      and payment, and unless this Warrant has been fully exercised or expired, a
      new
      Warrant representing the portion of Shares, if any, with respect to which this
      Warrant shall not then have been exercised shall also be issued to the holder
      hereof as soon as possible but in any event within five (5) days.

     

    3.  Stock
      Fully Paid, Reservation of Shares.
      All
      Shares that may be issued upon the exercise of this Warrant will, upon issuance,
      be duly and validly authorized and issued, fully paid and nonassessable, and
      will be free from all transfer taxes, liens and charges with respect to the
      issue thereof and assuming payment of the applicable consideration for all
      Shares so purchased, legally and validly owned by the Holder. During the period
      within which this Warrant may be exercised, the Company will at all times have
      authorized, and reserved for the sole purpose of the issue upon the exercise
      of
      the purchase rights evidenced by this Warrant, a sufficient number of shares
      of
      its Common Stock to provide for the exercise of the rights represented by this
      Warrant; and if at any time the number of authorized shares of Common Stock
      shall not be sufficient to effect the exercise of this Warrant, the Company
      will
      take such corporate action as may be necessary to increase its authorized shares
      of Common Stock to such number of shares as shall be sufficient for such
      purpose; the Company shall have analogous obligations with respect to any other
      securities or property issuable upon exercise of this Warrant. As long as this
      Warrant shall be outstanding, the Company shall use its best efforts to cause
      all shares of Common Stock issuable upon exercise of this Warrant to be listed
      and/or quoted on all securities exchanges and/or Nasdaq or other medium on
      which
      such shares may then be listed.

     

    4.  Adjustment
      of Warrant Price and Number of Shares.
      The
      number and kind of securities purchasable upon the exercise of this Warrant
      and
      the Warrant Price shall be subject to the adjustment from time to time upon
      the
      occurrence of certain events, as follows:

     

    (a)  No
      Impairment.
      The
      Company shall not, by amendment of its Certificate of Incorporation or By-laws
      or through any reorganization, recapitalization, transfer of assets,
      consolidation, merger, dissolution, issue or sale of securities or any other
      voluntary action, avoid or seek to avoid the observance or performance of any
      of
      the terms to be observed or performed hereunder by the Company, but will at
      all
      times in good faith assist in the carrying out of all the provisions of this
      Section 4 and in the taking of all such action as may be necessary or
      appropriate in order to protect the rights of the Holder against
      impairment.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

     

    (b)  Below
      Exercise Price Issuance; Stock Dividends; Etc.
      

     

    	(i)  	
            Sale
              of Shares Below Warrant
              Price.

          

     

    (A)  If
      at any
      time or from time to time after the date hereof the Company issues or sells
      shares of Common Stock or Common Stock Equivalents (as hereinafter defined)
      (other than as a dividend or other distribution on any class of stock as
      provided in Section 4(b)(ii)
      below,
      or
      a subdivision or combination of shares as provided in Section 4(b)(iii)
      below)
      for an Effective
      Price (as hereinafter defined) that is less than the
      Warrant
      Price then in effect,
      then,
      and in each such case, the then existing Warrant
      Price shall be reduced, as of the opening of business on the date of
such
      issue or sale,
      to
the
      Effective Price. For purposes hereof,

     

    (I)  a
      “Common
      Stock Equivalent”
shall
      mean each share of Common Stock into which securities or property or rights
      are
      convertible, exchangeable or exercisable for or into shares of Common Stock,
      or
      otherwise entitle the holder thereof to receive directly or indirectly, any
      of
      the foregoing (provided
      that the
      Warrant Price shall be adjusted to reflect any termination of such instruments
      prior to the exercise of this Warrant); and 

     

    (II)  the
      “Effective
      Price”
of
      

     

    (x)
       a
      Common
      Stock Equivalent shall mean the sum of (x) the fair market value of the
      consideration paid for such security plus (y) the fair market value of the
      minimum consideration, if any, to be paid for the conversion, exercise or
      exchange of such security for or into each share of Common Stock, in each case
      on a per share of Common Stock basis (provided
      that the
      Warrant Price shall be adjusted to reflect adjustments to the Effective Price
      based upon any change in such minimum consideration to be paid prior to the
      exercise of this Warrant) and 

     

    (y)
       a
      share
      of Common Stock issued by the Company (other than upon the conversion, exercise
      or exchange of Common Stock Equivalents) shall be the fair market value of
      the
      consideration paid for such share of Common Stock.

     

    (B)  Consideration
      Received for Securities.
      For the
      purpose of making any adjustment required under this Section 4(b)(i),
      the
      consideration received by the Company for any issue or sale of securities shall
      (x) to
      the
      extent it consists of cash, be computed at the gross amount of cash received
      by
      the Company prior to deduction of any underwriting or similar commissions,
      compensation or concessions paid or allowed by the Company in connection with
      such
      issue or sale and
      without deduction of any expenses payable by the Company, and
      (y) to
      the
      extent it consists of property other than cash, be computed at the fair market
      value of that property as determined, in good faith, by the Board of Directors,
      and if
      additional
      shares of Common Stock and/or Common Stock Equivalents
      are
      issued or sold together with other stock or securities or other assets of the
      Company for a consideration which covers both, be computed as the portion of
      the
      consideration so received that may be reasonably determined, in good faith,
      by
      the Board of Directors to be allocable to such additional shares of Common
      Stock
and/or
      Common Stock Equivalents, which determination shall be subject to the approval
      of the
      Holder; provided
      that, in
      the event the Holder does not agree with the Company's determination of the
      value of such consideration, the 

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

       

       

      parties
        shall mutually agree upon and appoint an appraiser which shall be commissioned
        to investigate the value of the property to be distributed and shall submit
        a
        notice of an appraisal of that value to the Company and to the
        Holder within thirty (30) days of such commission. The appraiser shall be
        instructed to determine such value without regard to income tax consequences
        to
        the recipient as a result of receiving consideration other than cash. The
        value
        determined by the appraiser shall be conclusive. 

    

     

    (ii)  Adjustment
      for Common Stock Dividends and Distributions.
      If, at
      any time after the date hereof, the Company makes, or fixes a record date for
      the determination of holders of Common Stock entitled to receive, a dividend
      or
      other distribution payable in additional shares of Common Stock or Common Stock
      Equivalents, in each such event the Warrant
      Price that is then in effect shall be decreased as of the time of such issuance
      or, in the event such record date is fixed, as of the
      close
      of business on such record date,
      by
      multiplying the Warrant
      Price then in effect by a fraction (A) the
      numerator of which is the total number of shares of Common Stock and Common
      Stock Equivalents issued and outstanding immediately prior to the time of such
      issuance or the
      close
      of business on such record date,
      and
(B) the
      denominator of which is the total number of shares of Common Stock and Common
      Stock Equivalents issued and outstanding immediately prior to the time of such
      issuance or the
      close
      of business on such record date plus
      the
      number of shares of Common Stock or Common Stock Equivalents issuable in payment
      of such dividend or distribution; provided,
      however,
      that if
      such record date is fixed and such dividend is not fully paid or if such
      distribution is not fully made on the date fixed therefor, the Warrant
      Price shall be recomputed accordingly as of the
      close
      of business on such record date and
      thereafter the Warrant
      Price shall be adjusted pursuant to this Section 4(b)(ii) to reflect the
      actual payment of such dividend or distribution.

     

    (iii)  Adjustments
      for Stock Splits, Stock Subdivisions and Combinations.
      If, at
      any time after the date hereof, the Company subdivides or combines the Common
      Stock, (A) in
      the
      case of a subdivision (including a stock split), the Warrant
      Price in effect immediately
      prior to such event
      shall be proportionately decreased and the number of shares of Common Stock
      purchasable hereunder shall be proportionately increased, and (B) in
      the
      case of a combination (including a reverse stock split), the Warrant
      Price in effect immediately
      prior to such event
      shall be proportionately increased and the number of shares of Common Stock
      purchasable hereunder shall be proportionately decreased. Any adjustment under
      this Section 4(b)(iii)
      shall
      become effective at the
      close
      of business on the date the
      subdivision or combination becomes effective.

     

    (iv)  Adjustments
      for Reclassification, Reorganization, Merger, Consolidation and
      Sale.
      In case
      of (A) any
      reclassification, reorganization, change or conversion of securities of the
      Common Stock (other than a change in par value, or from par value to no par
      value) into other shares or securities of the Company, or (B) any
      merger or consolidation of the Company with or into another entity (other than
      a
      merger or consolidation with another entity in which the Company is the
      acquiring and the surviving entity and that does not result in any
      reclassification or change of the Common Stock),
      or
(C) any
      sale
      of all or substantially all the assets of the Company, the 

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

       

       

      Holder
        shall
        have the right to receive, in lieu of the shares of Common Stock for
        which
        this Warrant is exercisable, the kind and amount of shares of stock and other
        securities, money and property receivable upon such reclassification,
        reorganization, change, merger or consolidation upon exercise by the Holder
        of
        the maximum number of shares of Common Stock for which this Warrant could
        have been exercised immediately
        prior to such reclassification,
        reorganization, change, merger, consolidation or sale, all subject to further
        adjustment as provided herein or with respect to such other securities or
        property by the terms thereof. The provisions of this clause (iv)
        shall
        similarly attach to successive reclassifications, reorganizations, changes,
        mergers, consolidations or sales.

    

     

    (c)  Other
      Distributions.
      In the
      event the Company provides the holders of its Common Stock with consideration
      that is not otherwise addressed in this Section 4 (including, without
      limitation, declaring a distribution payable in securities, assets, cash or
      evidences of indebtedness issued by other persons or the Company (excluding
      cash
      dividends declared and paid by the Company out of retained earnings), then,
      in
      each such case, the Holder shall be entitled to a pro rata
      share of
      any such distribution as though the Holder was a holder of the number of shares
      of Common Stock of the Company issuable upon the exercise of this Warrant in
      whole as of the record date fixed for the determination of the holders of Common
      Stock of the Company entitled to receive such distribution.

     

    (d)  Recapitalizations.
      If at
      any time there occurs a recapitalization of the Common Stock (other than a
      subdivision, combination, merger, consolidation or sale of assets provided
      for
      in this Section 4), the Holder shall be entitled to receive upon exercise
      of this Warrant the number of shares of capital stock or other securities or
      property of the Company or otherwise, to which a holder of the Common Stock
      deliverable upon exercise would have been entitled on such recapitalization.
      In
      any such case, appropriate adjustment shall be made in the application of the
      provisions of this Section 4 with respect to the rights of the Holder after
      the
      recapitalization to the end that the provisions of this Section 4 (including
      adjustment of the Warrant Price then in effect and the number of shares
      purchasable upon exercise of this Warrant) shall be applicable after that event
      as nearly equivalent as may be practicable.

     

    (e)  Notice
      of Adjustments.
      Whenever there shall be any change pursuant to this Section 4, the Company
      shall
      prepare a certificate setting forth, in reasonable detail, the event requiring
      the change and the kind and amount of shares of stock and other securities,
      money and property subsequently issuable upon an exercise hereof. Such
      certificate shall be signed by its chief financial officer and shall be
      delivered to the Holder or such other person as the Holder or any successor
      notice recipient may designate.

     

    (f)  Fractional
      Shares; Rounding.
      No
      fractional shares of Common Stock will be issued in connection with any exercise
      hereunder, but in lieu of such fractional shares, the number of shares of Common
      Stock to be received by the Holder upon exercise shall be
      rounded up to the nearest whole share.
      All
      calculations under this Section 4 shall be made to the nearest cent or to
      the nearest one-hundredth of a share, as the case may be.

     

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    5.  Compliance
      with Securities Act; Disposition of Warrant or Shares of Common
      Stock.
      

     

    (a) The
      Holder, by acceptance hereof, agrees that this Warrant and the Shares to be
      issued upon the exercise hereof are being acquired for investment and that
      such
      holder will not offer, sell or otherwise dispose of this Warrant or any Shares
      to be issued upon the exercise hereof except under circumstances which will
      not
      result in a violation of applicable securities laws. All Shares issued upon
      exercise of this Warrant (unless registered under the Act) shall be stamped
      or
      imprinted with a legend in substantially the following form:

     

    “THE
      SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
      OR APPLICABLE STATE SECURITIES LAWS AND NO INTEREST THEREIN MAY BE SOLD,
      TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS (1) A REGISTRATION STATEMENT WITH
      RESPECT TO SUCH SECURITIES SHALL BE EFFECTIVE UNDER THE ACT AND ANY APPLICABLE
      STATE SECURITIES LAWS OR (2) SUCH SECURITIES ARE TRANSFERRED PURSUANT TO RULE
      144 PROMULGATED UNDER THE ACT (OR ANY SUCCESSOR RULE) OR (3) COMPREHENSIVE
      HEALTHCARE SOLUTIONS, INC. SHALL HAVE RECEIVED AN OPINION OF COUNSEL REASONABLY
      SATISFACTORY TO IT THAT NO VIOLATION OF THE ACT WILL BE INVOLVED IN SUCH
      TRANSFER.”

     

    (b)  This
      Warrant may be transferred or assigned, in whole or in part, by the Holder.
      This
      Warrant and all of the provisions hereof shall be binding upon and inure to
      the
      benefit of the Company, the Holder and their respective successors and
      assigns.

     

    (c)  Pursuant
      to a Registration Rights Agreement of even date between the Company and the
      Holder, the Holder has been granted certain registration rights with respect
      to
      the resale of the Shares issuable upon the exercise thereof.

     

    6.  Rights
      as a Shareholder.
      The
      Holder, as such, shall not be entitled to vote or receive dividends or be deemed
      the holder of Shares or any other securities of the Company which may at any
      time be issuable on the exercise hereof, nor shall anything contained herein
      be
      construed to confer upon the Holder, as such, any right to vote as a shareholder
      for the election of directors or upon any matter submitted to shareholders
      at
      any meeting thereof, or to receive notice of meetings, or to receive dividends
      or subscription rights or otherwise until this Warrant is exercised and the
      Shares purchasable upon the exercise hereof shall have become deliverable,
      as
      provided herein.

     

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    7.  Representations
      and Warranties.
      The
      Company represents and warrants to the Holder as follows:

     

    (a) The
      Company has all requisite corporate power and authority to authorize and execute
      this Warrant and the certificates evidencing the Shares and to perform all
      obligations and undertakings under this Warrant; 

     

    (b)
       This
      Warrant has been duly authorized and executed by the Company and is a valid
      and
      binding obligation of the Company enforceable in accordance with its
      terms;

     

    (c) The
      Shares have been duly authorized and reserved for issuance by the Company and,
      when issued in accordance with the terms hereof, will be validly issued, fully
      paid and nonassessable; and

     

    (d)  Neither
      the execution and delivery of this Warrant, nor the issuance of the Shares
      upon
      exercise of this Warrant in accordance with the terms hereof, will be
      inconsistent with the Company’s Certificate of Incorporation or By-laws, as
      amended, and do not and will not constitute a default under any indenture,
      mortgage, contract, other instrument, judgment, decree or order to which the
      Company is a party or by which it is bound.

     

    8.  Miscellaneous.
      (a)  This Warrant represents the entire agreement between the parties
      hereto with respect to the subject matter thereof. This Warrant may not be
      modified or amended, or any provisions hereof waived, except by written
      agreement of the Company and the Holder.

     

    (b)  All
      notices, demands and requests of any kind to be delivered to any party in
      connection with this Warrant shall be in writing and shall be deemed to have
      been duly given if personally or hand delivered or if sent by a recognized
      overnight delivery courier or by registered or certified mail, return receipt
      requested and postage prepaid, or by facsimile transmission addressed as
      follows:

     

              
      (i)  if
      to the
      Company, to:

     

    Comprehensive
      Healthcare Solutions, Inc.

    45
      Ludlow
      Street, Suite 602

    Yonkers,
      New York 10705

    Attention:
      John H. Treglia, President

    Facsimile:
      (914) 375-3696

     

     

    
 

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

     

    with
      a
      copy to:

    

    Anslow
      & Jaclin, LLP

    195
      Route
      9, Suite 204

    Manalapan,
      New Jersey 07726

    Attention:
      Gregg E. Jaclin, Esq.

    Facsimile:
      (732) 577-1188

     

    (ii)  if
      to the
      Holder, to:

     

    Comprehensive
      Associates LLC

    64
      Shelter Lane

    Roslyn,
      New York 11577

    Attention:
      Robyn Schreiber

    Facsimile:
      (516) 621-9172

    

    with
      a
      copy to:

    

    Certilman
      Balin Adler & Hyman, LLP

    90
      Merrick Avenue, 9th Floor

    East
      Meadow, New York 11554

    Attention:
      Fred Skolnik, Esq.

    Facsimile:
      (516) 296-7111

    

    or
      to
      such other address as the party to whom notice is to be given may have furnished
      to the other party hereto in writing in accordance with provisions of this
      Section 7. Any such notice or communication shall be deemed to have been
      effectively given (i) in the case of personal or hand delivery, on the date
      of such delivery, (ii) in the case of a recognized overnight delivery
      courier, on the business day after the date when sent, (iii) in the case of
      mailing, on the third business day following that day on which the piece of
      mail
      containing such communication is posted and (iv) in the case of facsimile
      transmission, on the date of transmission. 

     

    (c)  The
      Company covenants to the Holder that upon receipt of a description of
      circumstances reasonably satisfactory to the Company of the loss, theft,
      destruction or mutilation of this Warrant and, in the case of any such loss,
      theft or destruction, upon receipt of an indemnity reasonably satisfactory
      to
      the Company, or in the case of any such mutilation upon surrender and
      cancellation of such Warrant, the Company will make and deliver a new Warrant,
      of like tenor, in lieu of the lost, stolen, destroyed or mutilated
      Warrant.

    

    (d)  The
      descriptive headings of the several sections and paragraphs contained in this
      Warrant are for reference purposes only and shall not affect in anyway the
      meaning or interpretation of this Warrant.

     

     

    
 

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

     

    (e)  This
      Warrant shall be governed by and construed in accordance with the internal
      laws
      of the State of New York, without giving effect to the principles of conflicts
      of laws. 

    

    (f)  The
      invalidity of any of the provisions of this Warrant shall not invalidate or
      otherwise affect any of the other provisions of this Warrant, which shall remain
      in full force and effect.

    

    (g)  The
      Company acknowledges that it has been represented by counsel in connection
      with
      this Warrant. Accordingly, any rule or law or any legal decision that would
      require the interpretation of any claimed ambiguities in this Warrant against
      the party that drafted it has no application and is expressly waived by the
      Company. The provisions of this Warrant shall be interpreted in a reasonable
      manner to give effect to the intent of the parties hereto.

    

    

    {Remainder
      of page intentionally left blank. Signature page
      follows.}

    

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

     

    IN
      WITNESS WHEREOF,
      the
      Company has caused this Warrant to be duly executed by a duly authorized officer
      as of the ____ day of August _, 2005.

     

    COMPREHENSIVE
      HEALTHCARE SOLUTIONS, INC.

     

    By:
      ______________________________

     

     

    John
      Treglia, President 

     

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

     

    FORM
      OF EXERCISE NOTICE

     

    To:     Comprehensive
      Healthcare Solutions, Inc.

            45
      Ludlow
      Street, Suite 602

    Yonkers,
      New York 10705

    Attention:
      John Treglia

    Facsimile:
      (914) 375-3696

    

     

    1.  The
      undersigned hereby elects to purchase __________ shares of Common Stock of
      Comprehensive Healthcare Solutions, Inc. pursuant to the terms of the attached
      Warrant, and tenders herewith full payment of the purchase price of such shares
      in cash. 

     

    2.  Please
      issue a certificate or certificates representing said shares in the name of
      the
      undersigned or in such other name or names as are specified below:

     

    (Name)

     

    (Address)

     

    3.  The
      undersigned represents that the aforesaid shares are being acquired for the
      account of the undersigned for investment and not with a view to, or for resale
      in connection with, the distribution thereof and that the undersigned has no
      present intention of distributing or reselling such shares in a manner that
      would cause the issuance of the underlying shares to be in violation of
      applicable securities laws.

     

     

     

    

     

    By:      

     

    

     

    Address:     

     

     

     

    

     

    Taxpayer
      Identification No.:   

     

    

     

    Date: 
      _________________________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}]]